Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Casi Pharmaceuticals Inc (NQ: CASI )

1.640 -0.089 (-5.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Casi Pharmaceuticals Inc

< Previous 1 2 3 4 Next >
Week In Review: Fosun Acquires VerImmune Cancer Immunotherapy In $125 Million Deal
Fosun Pharma acquired China rights to a novel broad cancer immunotherapy candidate from VerImmune of Baltimore in an $125 million agreement. Fosun will pay VerImmune up to $125 million in upfront and... 
Via Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting the final day of trading for the week with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
CASI Pharmaceuticals: Q1 Earnings Insights
CASI Pharmaceuticals (NASDAQ:CASI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: CASI Pharmaceuticals Q1 Earnings
CASI Pharmaceuticals (NASDAQ:CASI) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: CASI Pharmaceuticals Q4 Earnings
  CASI Pharmaceuticals (NASDAQ:CASI) reported its Q4 earnings results on Monday, March 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
61 Stocks Moving In Thursday's Mid-Day Session
 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
41 Stocks Moving In Monday's Mid-Day Session
Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back and get ready for another busy week of trading as we start it off with the biggest pre-market stock movers for Monday! 
Via InvestorPlace
30 Stocks Moving in Monday's Pre-Market Session
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) rose 25.2% to $2.09 in pre-market trading after gaining around 10% on Friday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another breakdown of all the biggest pre-market stock movers as we go over the news for Wednesday morning. 
Via InvestorPlace
27 Stocks Moving in Wednesday's Pre-Market Session
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares rose 38.5% to $1.87 in pre-market trading after gaining around 5% on Tuesday. Brickell Biotech, Inc. (NASDAQ: BBI) rose 29% to $0.... 
Via Benzinga
HFCAA News: 128 Chinese Stocks the SEC Could Delist
The SEC has released a massive list of Chinese stocks that could face delisting on Holding Foreign Companies Accountable Act news. 
Via InvestorPlace
Most Chinese Biotech Stocks Can Continue US Listing After New Audit Framework
 
Via Benzinga
Baidu, iQIYI Explore Options After US SEC Added Them To Provisional List Pending Audit Review
 
Via Benzinga
CASI Pharmaceuticals's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q4, CASI Pharmaceuticals's (NASDAQ:CASI) reported sales totaled $9.16 million. Despite a 46.15% increase in earnings, the company posted a loss of $5.39... 
Via Benzinga
Earnings Scheduled For March 28, 2022
Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million. 
Via Benzinga
Earnings Outlook For CASI Pharmaceuticals
CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
How To Attend CASI Pharmaceuticals Q4 2021 Earnings Conference Call
CASI Pharmaceuticals (NASDAQ:CASI) will host a conference call at 08:00 AM ET on March 28, 2022, to discuss Q4 2021 earnings results. How to Attend CASI Pharmaceuticals (... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Calyxt (NASDAQ:CLXT) shares rose 12.4% to $1.63 during Friday's pre-market session. The company's market cap stands at $62.7 million. Better Therapeutics (... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Anixa Biosciences (NASDAQ:ANIX) s... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Idera Pharmaceuticals (NASDAQ:IDRA) stock rose 13.0% to $0.71 during Friday's pre-market session. The market value of their outstanding shares is at $37.7... 
Via Benzinga
Casi Pharma-Partnered BioInvent's Lead Cancer Program Gets FDA Orphan Drug Tag
The FDA has granted Orphan Drug Designation to BioInvent International AB's (OTC: BOVNF) BI-1206, an anti-FcyRllB antibody, for follicular lymphoma (FL)... 
Via Benzinga
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral... 
Via Benzinga
BioInvent and CASI Pharmaceuticals Announce CTA Approval for Clinical Studies of BI-1206 in NHL in China
LUND, SE / ACCESSWIRE / December 10, 2021 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) , a biotech company focused on the discovery and development of novel and first-in-class... 
From BioInvent International
Via AccessWire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.